claim
Research into strategies to maintain or augment the antidepressant response to ketamine has yielded disappointing results for drugs including clonidine, D-cycloserine, lamotrigine, lithium, rapamycin, rapamycin, and riluzole.

Authors

Sources

Referenced by nodes (3)